{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:00:16Z","timestamp":1772895616513,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03107-6","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T18:13:08Z","timestamp":1745604788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Carboplatin Co-loaded 5-Fluorouracil Nanoparticles Conjugated with Trastuzumab for Targeted Therapy in HER2+ Heterogeneity Breast Cancer"],"prefix":"10.1208","volume":"26","author":[{"given":"Akshay Kumar","family":"Lunawat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debanjan","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riya","family":"Shivgotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarjana","family":"Raikwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamsher","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani","family":"Chandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subheet Kumar","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5857-2624","authenticated-orcid":false,"given":"Shubham","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"issue":"2","key":"3107_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.63053\/ijhes.23","volume":"1","author":"M Aghaei","year":"2023","unstructured":"Aghaei M. The breast cancer, a global health crisis. Intl J New Findings Health Educ Sci (IJHES). 2023;1(2):79\u201387.","journal-title":"Intl J New Findings Health Educ Sci (IJHES)"},{"key":"3107_CR2","first-page":"9248","volume":"11","author":"EB Effiong","year":"2022","unstructured":"Effiong EB, et al. Breast cancer\u2014review. J Glob Biosci. 2022;11:9248\u201357.","journal-title":"J Glob Biosci"},{"issue":"8","key":"3107_CR3","doi-asserted-by":"publisher","first-page":"R105","DOI":"10.1530\/ERC-21-0293","volume":"29","author":"A Alataki","year":"2022","unstructured":"Alataki A, Dowsett M. Human epidermal growth factor receptor-2 and endocrine resistance in hormone-dependent breast cancer. Endocr Relat Cancer. 2022;29(8):R105\u201322.","journal-title":"Endocr Relat Cancer"},{"key":"3107_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.breast.2021.07.019","volume":"59","author":"F Schettini","year":"2021","unstructured":"Schettini F, Prat A. Dissecting the biological heterogeneity of HER2-positive breast cancer. The breast. 2021;59:339\u201350.","journal-title":"The breast"},{"key":"3107_CR5","unstructured":"Guo CC et al. Molecular profile of bladder cancer progression to clinically aggressive subtypes. Nature Rev Urol 2024;1\u201315."},{"issue":"5","key":"3107_CR6","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.3390\/ijms23052856","volume":"23","author":"P Tagde","year":"2022","unstructured":"Tagde P, et al. Nanomedicine-based delivery strategies for breast cancer treatment and management. Int J Mol Sci. 2022;23(5):2856.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3107_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/1061186X.2022.2055045","volume":"30","author":"Y Omidi","year":"2022","unstructured":"Omidi Y, et al. Recent advances in nanoscale targeted therapy of HER2-positive breast cancer. J Drug Target. 2022;30(7):687\u2013708.","journal-title":"J Drug Target"},{"issue":"4","key":"3107_CR8","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3390\/cancers15041260","volume":"15","author":"N Riaz","year":"2023","unstructured":"Riaz N, et al. Recent advances in optimizing radiation therapy decisions in early invasive breast cancer. Cancers. 2023;15(4):1260.","journal-title":"Cancers"},{"key":"3107_CR9","doi-asserted-by":"crossref","unstructured":"Edis Z et al. Nanocarriers-mediated drug delivery systems for anticancer agents: an overview and perspectives. Intl J Nanomed 2021;1313\u20131330.","DOI":"10.2147\/IJN.S289443"},{"key":"3107_CR10","doi-asserted-by":"publisher","first-page":"120082","DOI":"10.1016\/j.ijpharm.2020.120082","volume":"592","author":"E da Silva Santos","year":"2021","unstructured":"da Silva Santos E, et al. EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles. Int J Pharm. 2021;592:120082.","journal-title":"Int J Pharm"},{"key":"3107_CR11","doi-asserted-by":"publisher","first-page":"114445","DOI":"10.1016\/j.addr.2022.114445","volume":"188","author":"Q Gao","year":"2022","unstructured":"Gao Q, et al. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment. Adv Drug Deliv Rev. 2022;188:114445.","journal-title":"Adv Drug Deliv Rev"},{"key":"3107_CR12","doi-asserted-by":"crossref","unstructured":"Lunawat AK et al. Revolutionizing cancer treatment: the role of chitosan nanoparticles in therapeutic advancements. J Drug Del Sci Technol. 2024;105661.","DOI":"10.1016\/j.jddst.2024.105661"},{"key":"3107_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/B978-0-323-96116-5.00017-X","volume-title":"Ionotropic Cross-Linking of Biopolymers","author":"A Azim","year":"2024","unstructured":"Azim A, et al. Ionotropic cross-linked drug delivery carriers made of grafted biopolymers. In: Ionotropic Cross-Linking of Biopolymers. Elsevier; 2024. p. 491\u2013532."},{"issue":"6","key":"3107_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s40005-022-00575-x","volume":"52","author":"S-H Lee","year":"2022","unstructured":"Lee S-H, et al. Quality by Design (QbD) application for the pharmaceutical development process. J Pharm Investig. 2022;52(6):649\u201382.","journal-title":"J Pharm Investig"},{"issue":"10","key":"3107_CR15","first-page":"3269","volume":"6","author":"P Chowdhury","year":"2021","unstructured":"Chowdhury P, et al. Bioactive nanotherapeutic trends to combat triple negative breast cancer. Bioact Mater. 2021;6(10):3269\u201387.","journal-title":"Bioact Mater"},{"issue":"22","key":"3107_CR16","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.3390\/polym13223910","volume":"13","author":"L Lozano Chamizo","year":"2021","unstructured":"Lozano Chamizo L, et al. Ionotropic gelation-based synthesis of chitosan-metal hybrid nanoparticles showing combined antimicrobial and tissue regenerative activities. Polymers. 2021;13(22):3910.","journal-title":"Polymers"},{"issue":"5","key":"3107_CR17","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1177\/0040517518755785","volume":"89","author":"T Risti\u0107","year":"2019","unstructured":"Risti\u0107 T, et al. The evaluation of the in vitro antimicrobial properties of fibers functionalized by chitosan nanoparticles. Text Res J. 2019;89(5):748\u201361.","journal-title":"Text Res J"},{"issue":"3","key":"3107_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/md20030156","volume":"20","author":"MK Amin","year":"2022","unstructured":"Amin MK, Boateng JS. Enhancing stability and mucoadhesive properties of chitosan nanoparticles by surface modification with sodium alginate and polyethylene glycol for potential oral mucosa vaccine delivery. Mar Drugs. 2022;20(3):156.","journal-title":"Mar Drugs"},{"key":"3107_CR19","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ijbiomac.2021.06.191","volume":"185","author":"J Kadkhoda","year":"2021","unstructured":"Kadkhoda J, et al. Advances in antibody nanoconjugates for diagnosis and therapy: A review of recent studies and trends. Int J Biol Macromol. 2021;185:664\u201378.","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"3107_CR20","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.3390\/molecules28062451","volume":"28","author":"K \u017belechowska-Matysiak","year":"2023","unstructured":"\u017belechowska-Matysiak K, et al. Doxorubicin-and Trastuzumab-modified gold nanoparticles as potential multimodal agents for targeted therapy of HER2+ cancers. Molecules. 2023;28(6):2451.","journal-title":"Molecules"},{"issue":"5","key":"3107_CR21","doi-asserted-by":"publisher","first-page":"2300191","DOI":"10.1002\/nano.202300191","volume":"5","author":"CT Selepe","year":"2024","unstructured":"Selepe CT, et al. Trastuzumab-based nanomedicines for breast cancer therapy: Recent advances and future opportunities. Nano Select. 2024;5(5):2300191.","journal-title":"Nano Select"},{"key":"3107_CR22","doi-asserted-by":"crossref","unstructured":"Naruphontjirakul P, Viravaidya-Pasuwat K. Development of anti-HER2-targeted doxorubicin\u2013core-shell chitosan nanoparticles for the treatment of human breast cancer. Intl J Nanomed. 2019;4105\u20134121.","DOI":"10.2147\/IJN.S198552"},{"key":"3107_CR23","unstructured":"Andrade SM. Nanoparticles as Nanocarriers of Resveratrol for Alzheimer\u2019s Disease. 2015, Universidade do Porto (Portugal)."},{"issue":"1","key":"3107_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/156720110790396517","volume":"7","author":"KS Yadav","year":"2010","unstructured":"Yadav KS, Sawant KK. Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation. Curr Drug Deliv. 2010;7(1):51\u201364.","journal-title":"Curr Drug Deliv"},{"issue":"1","key":"3107_CR25","doi-asserted-by":"publisher","first-page":"12288","DOI":"10.1038\/s41598-020-68732-6","volume":"10","author":"S Das","year":"2020","unstructured":"Das S, Wong AB. Stabilization of ferulic acid in topical gel formulation via nanoencapsulation and pH optimization. Sci Rep. 2020;10(1):12288.","journal-title":"Sci Rep"},{"key":"3107_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.matchemphys.2018.08.064","volume":"220","author":"PK Baruah","year":"2018","unstructured":"Baruah PK, et al. Optimization of copper nanoparticles synthesized by pulsed laser ablation in distilled water as a viable SERS substrate for karanjin. Mater Chem Phys. 2018;220:111\u20137.","journal-title":"Mater Chem Phys"},{"key":"3107_CR27","first-page":"1","volume-title":"Handbook of consumer nanoproducts","author":"MM Eid","year":"2022","unstructured":"Eid MM. Characterization of Nanoparticles by FTIR and FTIR-Microscopy. In: Handbook of consumer nanoproducts. Springer; 2022. p. 1\u201330."},{"key":"3107_CR28","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.ijbiomac.2020.11.099","volume":"167","author":"R Javed","year":"2021","unstructured":"Javed R, et al. Chitosan capping of CuO nanoparticles: Facile chemical preparation, biological analysis, and applications in dentistry. Int J Biol Macromol. 2021;167:1452\u201367.","journal-title":"Int J Biol Macromol"},{"key":"3107_CR29","doi-asserted-by":"crossref","unstructured":"Hossain M, Limbach PA. A comparison of MALDI matrices. Electrospray and MALDI Mass Spectrometry, Fundamentals, Instrumentation, Practicalities, and Biological Applications. 2010;215\u2013261.","DOI":"10.1002\/9780470588901.ch7"},{"key":"3107_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.colsurfb.2017.12.001","volume":"162","author":"A Badkas","year":"2018","unstructured":"Badkas A, et al. Modulation of in vitro phagocytic uptake and immunogenicity potential of modified Herceptin\u00ae-conjugated PLGA-PEG nanoparticles for drug delivery. Colloids Surf, B. 2018;162:271\u20138.","journal-title":"Colloids Surf, B"},{"issue":"8","key":"3107_CR31","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1021\/mp400154a","volume":"10","author":"S Modi","year":"2013","unstructured":"Modi S, Anderson BD. Determination of drug release kinetics from nanoparticles: overcoming pitfalls of the dynamic dialysis method. Mol Pharm. 2013;10(8):3076\u201389.","journal-title":"Mol Pharm"},{"key":"3107_CR32","doi-asserted-by":"crossref","unstructured":"Shafiei F et al. Drug release kinetics and biological properties of a novel local drug carrier system. Dental Res J. 2021;18.","DOI":"10.4103\/1735-3327.330875"},{"issue":"1","key":"3107_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/21691401.2017.1304403","volume":"46","author":"F Haghiralsadat","year":"2018","unstructured":"Haghiralsadat F, et al. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery. Artif Cells Nanomed Biotechnol. 2018;46(1):169\u201377.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"5","key":"3107_CR34","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/foods10050949","volume":"10","author":"M Mohammed","year":"2021","unstructured":"Mohammed M, Alqahtani N, El-Shafie H. Development and evaluation of an ultrasonic humidifier to control humidity in a cold storage room for postharvest quality management of dates. Foods. 2021;10(5):949.","journal-title":"Foods"},{"issue":"3","key":"3107_CR35","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1021\/tx500479m","volume":"28","author":"LQ Chen","year":"2015","unstructured":"Chen LQ, et al. Nanotoxicity of silver nanoparticles to red blood cells: size dependent adsorption, uptake, and hemolytic activity. Chem Res Toxicol. 2015;28(3):501\u20139.","journal-title":"Chem Res Toxicol"},{"key":"3107_CR36","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.ijbiomac.2017.02.030","volume":"98","author":"U Gupta","year":"2017","unstructured":"Gupta U, et al. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan. Int J Biol Macromol. 2017;98:810\u20139.","journal-title":"Int J Biol Macromol"},{"issue":"12","key":"3107_CR37","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.3390\/life13122311","volume":"13","author":"BL Witt","year":"2023","unstructured":"Witt BL, Tollefsbol TO. Molecular, cellular, and technical aspects of breast cancer cell lines as a foundational tool in cancer research. Life. 2023;13(12):2311.","journal-title":"Life"},{"key":"3107_CR38","unstructured":"Bruckner DM. Quantitative understandings of human in vitro drug response relationships to in vivo model systems. 2019, Rensselaer Polytechnic Institute, Troy, NY"},{"issue":"10","key":"3107_CR39","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.2174\/1389201024666230818124025","volume":"25","author":"N Gulzar","year":"2024","unstructured":"Gulzar N, et al. Acute toxicity, anti-diabetic, and anti-cancerous potential of Trillium govanianum-conjugated silver nanoparticles in Balb\/c mice. Curr Pharm Biotechnol. 2024;25(10):1304\u201320.","journal-title":"Curr Pharm Biotechnol"},{"key":"3107_CR40","doi-asserted-by":"publisher","first-page":"101817","DOI":"10.1016\/j.jddst.2020.101817","volume":"58","author":"S Thakur","year":"2020","unstructured":"Thakur S, et al. Thermosensitive injectable hydrogel containing carboplatin loaded nanoparticles: A dual approach for sustained and localized delivery with improved safety and therapeutic efficacy. J Drug Del Sci Technol. 2020;58:101817.","journal-title":"J Drug Del Sci Technol"},{"issue":"3","key":"3107_CR41","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4103\/epj.epj_29_20","volume":"19","author":"NA Wani","year":"2020","unstructured":"Wani NA, et al. Biological evaluation of ethyl acetate extract of Chaetomium cupreum against Ehrlich ascites carcinoma cells in Swiss albino mice. Egypt Pharmaceut J. 2020;19(3):274\u201382.","journal-title":"Egypt Pharmaceut J"},{"issue":"8","key":"3107_CR42","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1517\/17425247.2014.917076","volume":"11","author":"P Chaubey","year":"2014","unstructured":"Chaubey P, Patel RR, Mishra B. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis. Expert Opin Drug Deliv. 2014;11(8):1163\u201381.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"3107_CR43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1039\/D3RA05933B","volume":"14","author":"MF Khan","year":"2024","unstructured":"Khan MF, et al. Preparation of novel S-allyl cysteine chitosan based nanoparticles for use in ischemic brain treatment. RSC Adv. 2024;14(1):160\u201380.","journal-title":"RSC Adv"},{"key":"3107_CR44","doi-asserted-by":"publisher","first-page":"116968","DOI":"10.1016\/j.carbpol.2020.116968","volume":"250","author":"LM Ferreira","year":"2020","unstructured":"Ferreira LM, et al. Design of chitosan-based particle systems: A review of the physicochemical foundations for tailored properties. Carbohyd Polym. 2020;250:116968.","journal-title":"Carbohyd Polym"},{"issue":"3","key":"3107_CR45","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.carbpol.2011.03.045","volume":"85","author":"P Li","year":"2011","unstructured":"Li P, et al. Development of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blends. Carbohyd Polym. 2011;85(3):698\u2013704.","journal-title":"Carbohyd Polym"},{"key":"3107_CR46","doi-asserted-by":"publisher","first-page":"104371","DOI":"10.1016\/j.jddst.2023.104371","volume":"82","author":"TT Dongsar","year":"2023","unstructured":"Dongsar TT, et al. Emerging potential of 5-Fluorouracil-loaded chitosan nanoparticles in cancer therapy. J Drug Del Sci Technol. 2023;82:104371.","journal-title":"J Drug Del Sci Technol"},{"issue":"33","key":"3107_CR47","doi-asserted-by":"publisher","first-page":"8593","DOI":"10.1016\/j.biomaterials.2011.07.057","volume":"32","author":"S Vrignaud","year":"2011","unstructured":"Vrignaud S, Benoit J-P, Saulnier P. Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials. 2011;32(33):8593\u2013604.","journal-title":"Biomaterials"},{"key":"3107_CR48","doi-asserted-by":"publisher","first-page":"119026","DOI":"10.1016\/j.powtec.2023.119026","volume":"430","author":"N Gaudel","year":"2023","unstructured":"Gaudel N, et al. Effect of stirring speed and particle size on couscous powder reconstitution. Powder Technol. 2023;430:119026.","journal-title":"Powder Technol"},{"key":"3107_CR49","doi-asserted-by":"publisher","first-page":"797804","DOI":"10.3389\/fphar.2022.797804","volume":"13","author":"A Abed","year":"2022","unstructured":"Abed A, et al. Platinum nanoparticles in biomedicine: Preparation, anti-cancer activity, and drug delivery vehicles. Front Pharmacol. 2022;13:797804.","journal-title":"Front Pharmacol"},{"issue":"5","key":"3107_CR50","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/ph14050437","volume":"14","author":"M Abdel-Tawab","year":"2021","unstructured":"Abdel-Tawab M. Considerations to be taken when carrying out medicinal plant research\u2014what we learn from an insight into the IC50 values, bioavailability and clinical efficacy of exemplary anti-inflammatory herbal components. Pharmaceuticals. 2021;14(5):437.","journal-title":"Pharmaceuticals"},{"issue":"6","key":"3107_CR51","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.3390\/ijms24065441","volume":"24","author":"RY da Silva","year":"2023","unstructured":"da Silva RY, et al. Microparticles in the development and improvement of pharmaceutical formulations: an analysis of in vitro and in vivo studies. Int J Mol Sci. 2023;24(6):5441.","journal-title":"Int J Mol Sci"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03107-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03107-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03107-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T17:02:44Z","timestamp":1751907764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03107-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["3107"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03107-6","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"5 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"114"}}